Extended experience with glycine for prevention of reperfusion injury after human liver transplantation.
Schemmer
P
P
Department of Surgery and the Childrens Hospital, Division of Metabolic and Endocrine Disease, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.
Golling
M
M
Kraus
T
T
Mehrabi
A
A
Mayatepek
E
E
Herfarth
Ch
Ch
Klar
E
E
D000241:Adenosine; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000493:Allopurinol; D001219:Aspartate Aminotransferases / Q000097:blood; D001926:Brain Death; D005978:Glutathione; D005998:Glycine / Q000008:administration & dosage / Q000627:therapeutic use*; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D007262:Infusions, Intravenous; D007328:Insulin; D008099:Liver; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000379:methods* / Q000502:physiology; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011887:Raffinose; D015427:Reperfusion Injury / Q000517:prevention & control*; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting / Q000379:methods
D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose; D005998:Glycine